0000899243-20-030338.txt : 20201103 0000899243-20-030338.hdr.sgml : 20201103 20201103205337 ACCESSION NUMBER: 0000899243-20-030338 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201026 FILED AS OF DATE: 20201103 DATE AS OF CHANGE: 20201103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH TARGET N V CENTRAL INDEX KEY: 0001259870 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 201284993 MAIL ADDRESS: STREET 1: ARA HILL TOP BUILDING, UNIT A-5 STREET 2: PLETTERIJWEG OOST 1, CURACAO CITY: WILLEMSTAD STATE: P8 ZIP: 000000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 201284994 BUSINESS ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-26 0 0001183765 Molecular Templates, Inc. MTEM 0001259870 BIOTECH TARGET N V ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1 CURACAO P8 00000 NETHERLANDS ANTILLES 0 0 1 0 0000924223 BB BIOTECH AG SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 CH-8200 SWITZERLAND 0 0 1 0 Common Stock 5069996 D Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. The Form 3 is jointly filed by BB Biotech AG and Biotech Target N.V. /s/ Martin Gubler 2020-11-02 /s/ Ivo Betschart 2020-11-02